obes
multifacet
pathophysiolog
condit
associ
lipid
accumul
adipocyt
dysfunct
impair
mitochondri
biogenesi
alter
metabol
profil
redox
imbal
excess
releas
inflammatori
mediat
intric
link
obesityassoci
phenotyp
henc
understand
mechan
redox
signal
pathway
molecular
target
exacerb
oxid
stress
crucial
improv
health
outcom
activ
nakatpasesrc
signal
downstream
pathway
reactiv
oxygen
speci
ro
recent
implic
obes
subsequ
nonalcohol
steatohepat
nash
caus
product
ro
creat
oxid
amplif
loop
apart
numer
studi
also
character
antioxid
properti
heme
oxygenas
suppress
obes
state
induct
restor
cellular
redox
process
contribut
inhibit
toxic
milieu
novelti
independ
mechan
present
uniqu
opportun
unravel
potenti
molecular
target
redox
regul
obes
nash
attenu
oxid
stress
understand
underli
molecular
mechan
associ
mediat
target
treatment
modal
may
provid
improv
therapeut
option
combat
clinic
disord
recent
advanc
understand
pathophysiolog
progress
metabol
syndrom
extens
obes
nonalcohol
steatohepat
nash
significantli
contribut
toward
develop
effect
pharmacolog
nonpharmacolog
strategi
howev
clinic
obes
remain
major
worldwid
epidem
contribut
increas
morbid
mortal
due
multifactori
origin
oxid
stress
remain
topic
great
interest
critic
involv
obesityassoci
phenotyp
mechan
thoroughli
investig
research
dysregul
product
offens
adipocytokin
obes
state
along
excess
gener
reactiv
oxygen
speci
ro
induc
alter
metabol
profil
predispos
one
associ
comorbid
although
product
ro
implic
import
part
adapt
respons
intracellular
signal
metabol
homeostasi
decreas
detoxifi
abil
oxid
scaveng
result
failur
prevent
oxid
damag
henc
interlink
relat
system
redox
imbal
releas
inflammatori
mediat
creat
inflammatori
milieu
significantli
affect
regul
metabol
pathway
consequ
lead
impair
physiolog
function
rise
derogatori
patholog
condit
consid
element
manifest
oxid
stress
obes
import
studi
novel
molecular
target
implement
innov
molecular
strategi
curb
oxid
injuri
light
understand
modul
redox
mechan
patholog
set
sever
dynam
cellular
target
process
propos
nakatpas
oxid
amplif
loop
one
profound
signal
mechan
causal
associ
exacerb
oxid
stress
diseas
state
implic
feedforward
mechan
specif
great
interest
activ
nakatpas
signal
correl
cellular
ro
cardioton
steroid
ct
present
excess
pathophysiolog
state
obes
activ
bind
ro
ct
induct
conform
chang
structur
modul
nakatpas
complex
stimul
signal
cascad
trigger
signal
pathway
activ
mediat
associ
overproduct
ro
inflammatori
marker
henc
creat
ro
amplif
loop
exacerb
alreadi
exist
condit
cumul
line
evid
suggest
trigger
downstream
signal
pathway
mediat
activ
nakatpas
signal
alter
adipocyt
phenotyp
induc
mitochondri
dysfunct
modul
transcript
posttranscript
regul
consequ
alter
system
metabol
profil
henc
understand
intersect
nakatpas
oxid
amplif
redox
imbal
obesityassoci
phenotyp
provid
viabl
target
diseas
intervent
subsequ
previou
studi
extens
character
antioxid
properti
heme
oxygenas
ho
system
isoform
crucial
stress
respons
protein
direct
molecular
effect
high
oxid
stress
implic
suppress
amend
redox
manipul
pathway
associ
adipocyt
dysfunct
alter
metabol
homeostasi
cumul
caus
increas
oxid
stress
induc
downregul
studi
document
induct
highlight
role
reduc
viscer
adipos
ablat
metabol
imbal
obesityassoci
phenotyp
establish
mechanist
basi
investig
antioxid
system
induct
applic
toward
abat
adipos
tissu
dysfunct
reduct
system
inflamm
enhanc
adiponectin
restor
metabol
balanc
upregul
molecul
intrins
role
modal
antioxid
exert
effect
metabol
alter
state
provid
insight
potenti
therapeut
applic
novelti
aforement
mechan
involv
regul
cellular
redox
present
increas
import
unravel
potenti
molecular
target
obesityassoci
phenotyp
subsequ
nash
review
aim
independ
uncov
mechanist
role
nakatpas
oxid
amplif
loop
well
mechan
associ
regul
increas
oxid
stress
obes
associ
comorbid
nash
review
assess
pharmacolog
nonpharmacolog
strategi
manipul
local
redox
signal
pathway
mediat
modul
mechan
individu
nakatpas
signal
cascad
extens
studi
due
recent
elucid
role
scaffold
signal
protein
studi
last
two
decad
sinc
emerg
xie
model
nakatpas
signal
demonstr
activ
signal
pathway
pivot
exacerb
oxid
stress
sever
diseas
model
sever
subunit
nakatpas
dissect
known
involv
distinct
ion
pump
function
subunit
nakatpas
signal
primarili
caus
structur
modul
lead
activ
membranebound
tyrosin
kinas
protein
src
presenc
excess
system
ro
diseas
condit
induc
carbonyl
subunit
lead
structur
format
molecular
complex
subsequ
lead
phosphoryl
activ
src
critic
bind
src
evid
shown
induc
n
domain
subunit
turn
transactiv
epitheli
growth
factor
receptor
egfr
consequ
rosmedi
activ
nakatpasesrcegfr
signal
initi
downstream
signal
cascad
includ
rasrafmekerk
pathway
result
amplifi
ro
subsequ
oxid
stress
releas
inflammatori
mediat
cumul
line
evid
also
suggest
regul
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
deriv
superoxid
gener
activ
src
henc
rosinduc
activ
nakatpas
signal
downstream
pathway
gener
ro
feedforward
mechan
creat
nakatpas
oxid
amplif
loop
shown
critic
diseas
state
cellular
gener
ro
system
redox
imbal
evid
link
nakatpasesrc
complex
activ
signal
mechan
also
trigger
releas
ct
like
ouabain
implic
sever
diseas
state
numer
studi
report
nakatpas
act
specif
receptor
ct
bind
ouabain
specif
receptor
site
induc
conform
chang
molecular
structur
disrupt
inact
src
kinas
interact
allow
src
activ
subsequ
molecular
activ
src
result
protein
interact
caus
assembl
activ
signal
cascad
includ
erk
cascad
plcpkc
pathway
well
inflammatori
pathway
associ
cellular
ro
gener
lead
oxid
stress
mechan
oper
activ
nakatpas
oxid
amplif
loop
present
increas
import
provid
therapeut
potenti
clinic
condit
associ
oxid
stress
redox
imbal
figur
structur
format
molecular
complex
subsequ
lead
phosphoryl
activ
src
critic
bind
src
evid
shown
induc
n
domain
subunit
turn
transactiv
epitheli
growth
factor
receptor
egfr
consequ
rosmedi
activ
nakatpasesrcegfr
signal
initi
downstream
signal
cascad
includ
rasrafmekerk
pathway
result
amplifi
ro
subsequ
oxid
stress
releas
inflammatori
mediat
cumul
line
evid
also
suggest
regul
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
deriv
superoxid
gener
activ
src
henc
rosinduc
activ
nakatpas
signal
downstream
pathway
gener
ro
feedforward
mechan
creat
nakatpas
oxid
amplif
loop
shown
critic
diseas
state
cellular
gener
ro
system
redox
imbal
evid
link
nakatpasesrc
complex
activ
signal
mechan
also
trigger
releas
ct
like
ouabain
implic
sever
diseas
state
numer
studi
report
nakatpas
act
specif
receptor
ct
bind
ouabain
specif
receptor
site
induc
conform
chang
molecular
structur
disrupt
inact
src
kinas
interact
allow
src
activ
subsequ
molecular
activ
src
result
protein
interact
caus
assembl
activ
signal
cascad
includ
erk
cascad
plcpkc
pathway
well
inflammatori
pathway
associ
cellular
ro
gener
lead
oxid
stress
mechan
oper
activ
nakatpas
oxid
amplif
loop
present
increas
import
provid
therapeut
potenti
clinic
condit
associ
oxid
stress
redox
imbal
figur
schemat
represent
nakatpas
oxid
amplif
loop
associ
mediat
induc
obesityassoci
phenotyp
activ
nakatpas
subunit
nonreceptorspecif
bind
ro
receptorspecif
bind
ct
diseas
state
phosphoryl
tyrosin
kinas
src
format
molecular
complex
activ
figur
schemat
represent
nakatpas
oxid
amplif
loop
associ
mediat
induc
obesityassoci
phenotyp
activ
nakatpas
subunit
nonreceptorspecif
bind
ro
receptorspecif
bind
ct
diseas
state
phosphoryl
tyrosin
kinas
src
format
molecular
complex
activ
downstream
signal
pathway
caus
alter
regul
marker
associ
inflamm
oxid
stress
adipogenesi
mitochondri
fatti
acid
oxid
releas
ro
creat
oxid
amplif
loop
caus
adipocyt
dysfunct
dyslipidemia
insulin
resist
mitochondri
dysfunct
contribut
obes
associ
nonalcohol
steatohepat
nash
arrow
shown
repres
upregul
downregul
respect
gene
process
ho
ratelimit
enzym
breakdown
heme
bodi
two
major
isoform
express
ubiquit
primarili
recogn
stress
respons
protein
induc
variou
oxid
agent
abil
degrad
heme
releas
oxid
destabil
heme
protein
respons
mediat
varieti
prooxid
inflammatori
stimuli
includ
oxid
stress
pharmacolog
compound
transit
metal
ultraviolet
light
helper
cell
cytokin
prostaglandin
lipopolysaccharid
dopamin
natur
substrat
heme
cleav
prooxid
heme
carbon
monoxid
co
biliverdin
convert
bilirubin
biliverdin
reductas
free
iron
abil
catabol
free
heme
produc
co
give
antiinflammatori
properti
upregul
receptor
antagonist
express
multipl
studi
demonstr
role
attenu
glucosemedi
cell
growth
arrest
reduc
apoptosi
adipocyt
hepat
cell
endotheli
cell
cardiac
myocyt
format
co
activ
mitogenactiv
protein
kinas
pathway
although
express
mediat
sever
benefici
effect
mainten
metabol
homeostasi
defici
lead
sustain
inflamm
nephropathi
tissu
iron
deposit
alter
express
also
implic
differenti
cell
growth
rat
fetal
model
transduct
human
led
increas
express
insulinlik
growth
receptor
vascular
endotheli
growth
factor
vegf
suggest
byproduct
co
bilirubin
play
critic
role
signal
process
enhanc
growth
factor
express
activ
sirtuin
implic
glucos
lipid
metabol
import
role
variou
cellular
metabol
pathway
recent
studi
suggest
molecular
interplay
demonstr
upregul
express
activ
rescu
express
two
form
cytoprotect
modul
model
obes
similarli
shown
regul
metabol
enzym
antioxid
defens
mechan
mitochondria
crucial
role
regul
mitochondri
metabol
respons
exercis
previous
publish
data
shown
involv
wide
rang
mitochondri
metabol
process
includ
depress
insulin
secret
pancreat
cell
promot
lipid
synthesi
regul
mitochondri
atp
control
apoptosi
regul
redox
cumul
mechan
oper
alter
express
relationship
mediat
oxid
stress
present
increas
import
pathophysiolog
condit
obes
subsequ
nash
figur
schemat
represent
relationship
increas
ro
obes
nash
intervent
increas
level
ro
caus
increas
inflammatori
insult
adipogen
gene
lead
increas
adipos
oxid
stress
dyslipidemia
exacerb
obes
nash
breakdown
heme
lead
product
bilirubin
carbon
monoxid
exert
potent
antioxid
antiinflammatori
properti
arrow
shown
repres
upregul
downregul
respect
gene
process
obes
associ
morbid
mortal
rise
make
global
epidem
obes
gener
character
increas
lipid
accumul
alter
endocrin
function
adipos
tissu
along
dysfunct
adipogenesi
one
major
hallmark
clinic
condit
numer
factor
contribut
alter
adipos
tissu
metabol
redox
imbal
larg
implic
pathogen
mechan
mainten
obes
phenotyp
oxid
stressinduc
adipogenesi
adipocyt
phenotyp
alter
increas
adipogen
marker
peroxisom
prolifer
fatti
acid
synthas
fa
mesodermspecif
transcript
protein
mest
along
proinflammatori
cytokin
includ
tumor
necrosi
factor
monocyt
chemoattract
excess
product
ro
subsequ
oxid
stress
obes
also
partli
attribut
mitochondri
dysfunct
alter
state
mitochondri
biogenesi
end
sever
studi
also
demonstr
import
role
interferongamma
dietinduc
obes
regul
system
inflamm
insulin
resist
obes
obes
state
alter
express
promot
oxid
ldl
product
oxldl
caus
adipos
tissu
macrophag
dysfunct
lead
increas
oxid
stress
releas
inflammatori
cytokin
alter
adipocyt
phenotyp
therefor
stimul
ro
subsequ
gener
inflammatori
gene
lead
increas
adipos
oxid
stress
dyslipidemia
exacerb
obes
nash
breakdown
heme
lead
product
bilirubin
carbon
monoxid
exert
potent
antioxid
antiinflammatori
properti
arrow
shown
repres
upregul
downregul
respect
gene
process
obes
associ
morbid
mortal
rise
make
global
epidem
obes
gener
character
increas
lipid
accumul
alter
endocrin
function
adipos
tissu
along
dysfunct
adipogenesi
one
major
hallmark
clinic
condit
numer
factor
contribut
alter
adipos
tissu
metabol
redox
imbal
larg
implic
pathogen
mechan
mainten
obes
phenotyp
oxid
stressinduc
adipogenesi
adipocyt
phenotyp
alter
increas
adipogen
marker
peroxisom
prolifer
fatti
acid
synthas
fa
mesodermspecif
transcript
protein
mest
along
proinflammatori
cytokin
includ
tumor
necrosi
factor
monocyt
chemoattract
excess
product
ro
subsequ
oxid
stress
obes
also
partli
attribut
mitochondri
dysfunct
alter
state
mitochondri
biogenesi
end
sever
studi
also
demonstr
import
role
interferongamma
dietinduc
obes
regul
system
inflamm
insulin
resist
obes
obes
state
alter
express
promot
oxid
ldl
product
oxldl
caus
adipos
tissu
macrophag
dysfunct
lead
increas
oxid
stress
releas
inflammatori
cytokin
alter
adipocyt
phenotyp
therefor
stimul
ro
subsequ
gener
inflammatori
mediat
creat
viciou
cycl
lead
alter
metabol
profil
increas
lipid
content
adipocyt
dysfunct
elucid
critic
role
nakatpas
oxid
amplif
loop
gener
ro
subsequ
oxid
stress
activ
downstream
pathway
highlight
import
dissect
mechanist
interplay
signal
mechan
obes
given
interconnect
oxid
stress
observ
led
equal
innov
hypothes
past
sever
year
extens
studi
perform
xieshapiro
laboratori
reveal
underli
molecular
mechan
phenotyp
alter
obes
caus
nakatpasemedi
signal
pathway
cumul
line
evid
demonstr
abil
nakatpas
oxid
amplif
loop
induc
adipocyt
dysfunct
murin
preadipocyt
increas
adipogenesi
complementari
vivo
studi
mice
model
western
diet
wd
intervent
show
increas
adipogen
marker
fa
mest
along
decreas
adiponectin
express
obes
addit
vivo
obes
model
exhibit
signific
decreas
adipos
tissu
fat
oxid
gene
marker
mitochondri
biogenesi
thermogenesi
includ
peroxisom
proliferatoractiv
receptor
gamma
coactiv
carnitin
uncoupl
ucp
mitofusin
mfn
subsequ
dietinduc
model
obes
alter
adipocyt
phenotyp
evidenc
decreas
number
adipocyt
increas
adipocyt
size
corrobor
alter
mediat
oxid
stressinduc
activ
nakatpas
oxid
amplif
loop
studi
evid
report
increas
protein
carbonyl
thiobarbitur
acid
reactiv
substanc
tbar
express
known
marker
oxid
stress
furthermor
decreas
express
subunit
subsequ
increas
express
csrc
downstream
phosphoerk
vivo
studi
accentu
activ
nakatpasesrc
signal
pathogenesi
obes
studi
also
report
activ
nakatpas
signal
obes
led
adipocytespecif
system
releas
inflammatori
mediat
well
insulin
resist
demonstr
increas
blood
glucos
homair
level
recent
publish
data
report
similar
find
suggest
role
adipocytespecif
nakatpas
signal
obes
evid
show
adipocyt
dysfunct
play
caus
role
pathogenesi
obes
includ
product
oxygen
radic
adipocyt
mitochondria
mitochondri
lipogenesi
lipolysi
furthermor
adipocyt
expos
system
oxid
stress
upregul
express
inflammatori
cytokin
macrophag
chemoattract
molecul
contribut
oxid
stress
aggrav
exist
pathophysiolog
condit
henc
adipocyt
creat
ideal
set
mechanist
action
nakatpas
signal
origin
effect
downstream
signal
pathway
adipocyt
phenotyp
alter
cumul
line
evid
also
suggest
activ
nadph
oxidas
model
obes
lead
subsequ
activ
reninangiotensin
system
ra
modulatori
mediat
ra
angiotensin
ii
angii
increas
cellular
heme
level
peroxynitrit
inactiv
produc
excess
ro
increas
releas
inflammatori
cytokin
decreas
express
suppress
redox
imbal
lead
dyslipidemia
insulin
resist
heme
increas
lipid
accumul
promot
cell
enlarg
induc
overexpress
adipogen
gene
pparg
adipocyt
protein
downregul
adiponectin
increas
heme
combin
increas
ro
lead
adipocyt
dysfunct
promot
inflammatori
infiltr
macrophag
inflammatori
molecul
increas
circul
level
glucos
decreas
cytoprotect
molecul
adiponectin
chronic
oxid
stress
lead
adipocyt
dysfunct
increas
lipid
accumul
induct
diseas
model
obes
provid
antioxid
set
increas
mitochondri
fusion
improv
secretori
profil
adipocyt
ie
increas
adiponectin
express
decreas
inflammatori
cytokin
releas
upregul
also
link
increas
insulin
sensit
improv
phosphoryl
insulin
receptor
improv
adipocyt
function
previous
publish
studi
shown
protect
role
inhibit
inflammatori
effect
sever
mediat
inflammatori
oxid
transcript
factor
nuclear
factor
kappalightchainenhanc
activ
b
cell
cjun
ntermin
kinas
jnk
primarili
involv
inflammatori
insult
stimul
inflammatori
pathway
creat
feedback
mechan
inflamm
evid
literatur
suggest
potenti
interact
adiponectin
adiponectin
protect
adipokin
signific
role
insulin
sensit
benefici
effect
triglycerid
adiponectin
level
invers
relat
adipos
report
demonstr
low
adiponectin
level
associ
increas
oxid
stress
express
abl
increas
adiponectin
level
furthermor
adipos
shown
attenu
axi
alter
adipocyt
phenotyp
inflammatori
marker
revers
redox
balanc
restor
upregul
develop
obes
often
associ
comorbid
includ
manifest
metabol
derang
lead
phenotyp
clinic
nash
cluster
abnorm
associ
obes
dyslipidemia
insulin
resist
known
caus
factor
nash
character
elev
hepat
adipos
insulin
resist
increas
free
fatti
acid
ffa
level
increas
inflammatori
mediat
numer
studi
observ
oxid
stress
inflamm
underli
pathogenesi
diseas
phenotyp
system
redox
imbal
along
inflammatori
mediat
increas
circul
level
ffa
obes
predispos
one
nash
redox
imbal
gener
highli
toxic
lipid
peroxid
induc
hepatocellular
injuri
fibrogenesi
contribut
alter
hepat
mitochondri
fatti
acid
oxid
triglycerid
accumul
steatosi
model
hepatocellular
injuri
increas
ro
also
link
impair
insulininsulinlik
growth
signal
subsequ
inhibit
pathway
impair
due
effect
ro
kinas
downstream
insulin
receptor
impair
pathway
may
partli
respons
damag
liver
imbalanc
redox
state
make
potenti
marker
insulin
resist
nash
associ
obes
clinic
manifest
experiment
model
dietinduc
obes
subsequ
nash
demonstr
largescal
product
ro
chemoattract
cytokin
excess
hepat
lipid
accumul
lead
product
fibrogen
cytokin
associ
nash
redox
imbal
exemplifi
import
investig
role
nakatpas
signal
downstream
mechan
target
clinic
condit
recent
publish
studi
demonstr
role
nakatpas
signal
aggrav
oxid
stress
subsequ
nash
use
vivo
model
wd
diet
studi
extens
illustr
increas
hepat
triglycerid
level
hepat
alt
ffa
fa
express
mice
fed
wd
diet
lipid
accumul
confirm
histolog
find
liver
tissu
exhibit
larg
number
vacuol
liver
signific
inflamm
inflammatori
cell
infiltr
liver
similarli
studi
also
demonstr
extens
signific
decreas
express
longchain
acylcoa
dehydrogenas
lcad
gene
associ
first
reaction
mitochondri
fatti
acid
oxid
import
regul
energi
homeostasi
along
signific
decreas
oxid
stress
induc
activ
nakatpas
signal
also
demonstr
increas
hepat
inflammatori
marker
includ
marker
macrophagekupff
cell
infiltr
histolog
stain
liver
tissu
exhibit
focal
portal
fibrosi
provid
evid
steatohepat
find
also
confirm
significantli
increas
express
type
collagen
level
sensit
indic
nash
along
increas
express
hepat
fibronectin
matrix
gene
relat
fibrogenesi
manifest
nash
dietinduc
vivo
model
mediat
oxid
stress
subsequ
activ
nakatpas
signal
confirm
increas
protein
carbonyl
along
western
blot
analysi
show
activ
nakatpas
signal
downstream
mediat
src
erk
observ
potenti
interest
perhap
great
import
consid
ro
amplif
nash
mediat
nakatpas
signal
pathway
may
thu
serv
potenti
therapeut
target
nash
character
oxid
stress
although
much
work
necessari
bridg
gap
recent
studi
hypothes
induct
attenu
hepat
fibrosi
rescu
cellular
attenu
inflamm
evid
link
increas
lipid
peroxid
product
releas
cytochrom
c
cell
lead
apoptosi
wherea
increas
oxid
stress
link
hepat
tissu
damag
caus
hepat
fibrosi
play
crucial
role
antioxid
cytoprotect
defens
mechan
liver
well
adipocyt
bilirubin
capabl
inhibit
lipid
peroxid
co
potent
antioxid
antiinflammatori
properti
protect
cell
oxid
stress
defici
mous
model
human
caus
sever
chronic
hepat
inflamm
iron
deposit
oxid
damag
liver
therapeut
potenti
mechan
action
still
larg
unknown
shown
attenu
experiment
steatohepat
protect
effect
cultur
hepatocyt
seem
indic
act
directli
hepat
tissu
upregul
gene
express
lead
reduct
hepat
lipid
accumul
improv
insulin
sensit
metabol
balanc
attenu
hepat
fibrosi
innov
breakthrough
discoveri
scaffold
function
nakatpas
signal
critic
role
exacerb
diseas
phenotyp
led
develop
synthet
peptid
pnaktid
specif
act
antagonist
signal
mechan
although
nonpharmacolog
effect
pnaktid
extens
demonstr
inhibit
activ
nakatpas
signal
henc
improv
diseas
phenotyp
specif
molecular
composit
sequenc
develop
pnaktid
detail
previous
exclus
allow
local
membran
compon
cell
essenti
inhibit
format
nakatpasesrc
complex
activ
downstream
pathway
studi
elucid
role
nakatpas
signal
obes
specif
demonstr
improv
obesityassoci
phenotyp
vitro
vivo
system
administr
pnaktid
show
improv
adipogenesi
mark
reduct
adipogen
marker
signific
reduct
overal
bodi
weight
reduc
viscer
subcutan
fat
content
studi
corrobor
find
demonstr
signific
decreas
oxid
stress
subsequ
releas
inflammatori
cytokin
caus
inhibit
nakatpas
subunit
express
src
downstream
erk
express
system
administr
pnaktid
similarli
administr
pnaktid
murin
model
steatohepat
show
mark
reduct
protein
carbonyl
along
significantli
reduc
inflammatori
marker
lipid
accumul
improv
insulin
resist
mitochondri
fatti
acid
oxid
histolog
examin
liver
tissu
also
show
effect
pnaktid
attenu
hepat
fibrosi
peptid
demonstr
effect
attenu
diseas
progress
atherosclerosi
evidenc
improv
lipid
accumul
cardiac
vasculatur
along
reduct
atherosclerot
plaqu
aorta
subsequ
administr
pnaktid
murin
experiment
urem
cardiomyopathi
model
show
reduc
cardiac
fibrosi
improv
cardiac
function
demonstr
echocardiograph
measur
henc
vitro
vivo
model
diseas
progress
mediat
activ
nakatpas
oxid
amplif
loop
downstream
signal
pathway
effect
blockag
signal
mechan
pnaktid
conclus
provid
strong
evid
therapeut
efficaci
recent
advanc
understand
obes
progress
led
investig
believ
adipocyt
dysfunct
play
caus
role
pathogenesi
obes
associ
comorbid
rather
previous
wellestablish
passiv
role
led
investig
util
genet
approach
use
lentivir
vector
wellestablish
yet
uniqu
promis
strategi
specif
target
adipocyt
consid
effect
system
administr
pnaktid
amelior
obes
phenotyp
recent
studi
employ
lentivir
construct
naktid
deriv
pnaktid
driven
adiponectin
promot
achiev
express
specif
adipocyt
inhibit
adipocyt
nakatpas
signal
lentiviru
naktid
adiponectin
promot
lentiadiponaktid
inject
intraperiton
mice
fed
wd
diet
find
highlight
import
nakatpas
oxid
amplif
loop
within
adipocyt
well
import
adipocyt
biolog
demonstr
improv
adipocyt
phenotyp
reduc
overal
bodi
weight
reduct
fat
content
lipid
accumul
attenu
oxid
stress
well
subsequ
reduct
inflammatori
marker
within
adipos
tissu
adipocyt
specif
express
naktid
improv
adipocyt
mitochondri
biogenesi
adapt
thermogenesi
evid
improv
system
metabol
profil
includ
reduc
insulin
resist
system
oxid
stress
plasma
level
inflammatori
cytokin
find
advanc
understand
basic
underli
cellular
mechan
oper
obes
strong
potenti
naktid
clinic
use
follow
demonstr
safe
administr
human
appear
target
nakatpas
oxid
amplif
loop
may
promis
term
efficaci
may
well
limit
offtarget
effect
use
nonpharmacolog
synthet
peptid
pnaktid
lentivir
approach
use
deriv
naktid
seem
highli
effect
antagon
nakatpasesrc
signal
sever
studi
also
employ
pharmacolog
strategi
inhibit
src
sever
pharmacolog
inhibitor
src
famili
kinas
report
previous
high
potenc
low
dose
includ
quinolinon
imminochromen
isothiazolon
anoth
pharmacolog
agent
potent
atpcompetit
inhibitor
src
well
studi
regard
nakatpas
signal
antagonist
pnaktid
studi
demonstr
effect
inhibit
basal
src
activ
cardiac
myocyt
significantli
greater
counterpart
pnaktid
furthermor
exhibit
similar
src
kinas
compar
pnaktid
howev
specif
modal
pnaktid
resid
membran
toward
disrupt
format
nakatpasesrc
receptor
complex
make
uniqu
yet
highli
effect
compar
induc
system
inhibit
src
pnaktid
specif
target
interact
nakatpasemedi
src
activ
limit
offtarget
effect
similarli
pharmacolog
inhibitor
src
offer
limit
specif
thu
limit
clinic
util
agent
attenu
oxid
stressinduc
activ
nakatpasesrc
signal
cascad
diseas
progress
associ
cobalt
protoporphyrin
copp
exogen
induc
theoret
act
protein
current
literatur
hypothes
neg
regul
adipogenesi
prevent
transcript
decreas
adipogenesi
lead
decreas
system
oxid
stress
inflammatori
cytokin
previou
studi
shown
induct
copp
reduc
viscer
adipos
attenu
metabol
imbal
increas
level
phosphoryl
akt
ampk
mtor
adipocyt
improv
oxid
stress
decreas
releas
inflammatori
cytokin
decreas
lipid
accumul
increas
adiponectin
level
pharmacolog
induct
limit
copp
hemin
epoxyeicosatrieno
acid
eet
implic
pharmacolog
induc
lentivir
vector
util
gene
target
therapi
variou
model
diseas
induct
proven
success
util
adipocytespecif
control
promot
lentivir
vector
express
decreas
adipos
vascular
dysfunct
improv
metabol
paramet
attenu
serum
level
inflammatori
cytokin
vivo
model
dietinduc
obes
induct
accompani
increas
preadipocyt
marker
decreas
mest
protein
correl
adipos
adipocyt
size
increas
express
also
result
decreas
level
gene
involv
adipogenesi
explain
decreas
adipos
addit
adiponectin
manufactur
adipocyt
increas
adipocytespecif
target
gene
result
improv
adipocyt
function
dietari
antioxid
shown
increas
express
vitro
potenti
use
natur
substanc
regul
immun
respons
care
address
studi
perform
scapagnini
et
al
show
low
concentr
caffeic
acid
phenethyl
ester
cape
curcumin
significantli
increas
express
astrocyt
curcumin
exert
cytoprotect
effect
endotheli
cell
mediat
increas
gene
express
thu
decreas
oxid
stress
believ
certain
activ
compon
medicin
plant
induc
gene
cape
curcumin
known
inhibit
nfkb
cyclooxygenas
activ
also
shown
inhibit
lipid
peroxid
cellular
growth
increas
physic
activ
shown
increas
induct
protect
oxid
stress
variou
model
well
preval
obes
increas
paramount
note
incid
comorbid
metabol
syndrom
nash
cardiovascular
diseas
go
increas
well
obes
associ
system
oxid
stress
suggest
impair
mitochondri
function
sever
inflamm
adipocyt
underli
pathogenesi
obes
hypertriglyceridemia
hyperglycemia
associ
increas
adipos
shown
increas
plasma
ffa
lead
increas
ro
gener
oxid
stress
imbal
oxid
stress
implic
nash
cardiovascular
diseas
understand
role
ro
oxid
stress
diseas
state
crucial
step
toward
better
therapeut
strategi
end
recent
advanc
understand
nakatpas
oxid
amplif
loop
provid
uniqu
opportun
better
elucid
redox
mechan
modifi
inflamm
manipul
local
redox
signal
pathway
highli
possibl
mechan
oper
nakatpas
oxid
amplif
loop
may
also
involv
mediat
yet
unidentifi
directli
modul
cellular
oxid
inflammatori
respons
although
pharmacolog
nonpharmacolog
intervent
target
mechan
demonstr
effect
possibl
implement
strategi
target
pathway
might
prove
better
clinic
outcom
howev
success
strategi
open
new
avenu
approach
toward
antagon
obes
subsequ
nash
bridg
gap
mice
human
shown
central
role
nakatpas
oxid
amplif
loop
pathogenesi
obes
well
commonli
associ
comorbid
specif
mechan
yet
elucid
role
upregul
also
character
signal
mechan
present
interest
therapeut
strategi
treatment
obes
nash
cardiovascular
diseas
offer
possibl
limit
offtarget
effect
increas
understand
molecular
biolog
cellular
mechan
involv
gain
understand
exact
sequenc
event
preced
diseas
also
potenti
new
biomark
act
warn
system
diseas
util
genet
therapi
specif
target
tissu
interest
lentivir
gene
therapi
model
allow
opportun
specif
express
target
tissu
limit
offtarget
effect
understand
mechan
signal
pathway
downstream
target
would
improv
understand
diseas
progress
fund
research
receiv
extern
fund
author
declar
conflict
interest
